The novel therapy of tirzepatide peptide represents a exciting advance in the handling of type 2 diabetes. Unlike existing medications, tirzepatide affects two pathways – glucagon-like peptide-1 (GLP-1) and the GIP https://tirzepatidepeptide587910.bloginder.com/42638479/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment